Press releaseGlobe Newswire
Apyx Medical
APYX · NASDAQ
$2.44+$0.02 (+0.83%)TodayMarket closed ·
Prev close $2.42
Latest news
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Press releaseGlobe Newswire
Apyx Medical Corporation Reports Second Quarter 2026 Financial Results
- Press releaseGlobe Newswire
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
- Press releasePRNewswire
Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway
- Press releaseGlobe Newswire
New Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion®
- Press releaseGlobe Newswire
Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™
- Press releaseGlobe Newswire
Apyx Medical Corporation Reports First Quarter 2026 Financial Results
- Press releaseGlobe Newswire
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026
- Press releasePRNewswire
Renuvion wins 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener"
- News
Earnings Scheduled For March 10, 2026
- News
Earnings Breakdown: Apyx Medical Q4
- Press releaseGlobe Newswire
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2025 Financial Results
- News
A Preview Of Apyx Medical's Earnings
- Press releaseGlobe Newswire
Apyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter and Full Year 2025 Revenue Results
- News
Apyx Medical Announces Approval, Commercial Roll Out Of Apyx One Console, Single-Use Handpieces In South Korea
- Press releaseGlobe Newswire
Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea
- Press releaseGlobe Newswire
Apyx Medical Corporation Announces Pricing of $10 Million Public Offering of Common Stock
- News
Earnings Scheduled For November 6, 2025
- Press releasePRNewswire
Renuvion® Brings Real Transformations to the Runway at Miami Swim Week
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- News
Earnings Scheduled For May 8, 2025
- Press releasePRNewswire
Renuvion Introduces Television Star Dolores Catania as Chief of Confidence
- Press releasePRNewswire
Renuvion wins 2025 NewBeauty Award for "Best Minimally Invasive Skin Tightener"
- News
A Look Ahead: Apyx Medical's Earnings Forecast
- Press releasePRNewswire
Renuvion Named #1 Trusted Body Contouring Technology by Doctors*
- Press releaseBusiness Wire
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Comparing the Use of Renuvion to a Competing Technology Following Liposuction or Body Contouring Procedures
- Press releaseBusiness Wire
Apyx Medical Corporation Reports Second Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook
- Press releaseBusiness Wire
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.